By his early 30s, Martin Shkreli had held a variety of impressive roles; he was the co-founder of multiple successful hedge funds, CEO of biotechnology firm Retrophin; and founder and CEO of Turing Pharmaceuticals. So, how did young Martin Shkreli, with no formal training in chemistry and a Bachelor's Degree in business administration, become a pharmaceutical CEO and have an estimated worth by Fortune magazine in 2016 of $45 million?
And how did Martin Shkreli only a few years later become a convicted felon worth practically nothing; referred to by the media as "Pharma Bro" and "the most hated man in America"?
And whatever happened to that unreleased Wu Tang Clan Album Martin Shkreli bought for $2 million? Find out today on the Controversial Figures Podcast.
Connect with us on Twitter: https://twitter.com/FiguresPodcast
Episode Sources:
- CNBC https://www.cnbc.com/2019/08/07/retrophin-paid-martin-shkreli-to-settle-all-legal-claims.html
- NetFlix Dirty Money, Drug Short episode
- Vanity Fair https://www.vanityfair.com/news/2015/12/martin-shkreli-pharmaceuticals-ceo-interview
- Wikipedia
- Martin Shkreli https://en.wikipedia.org/wiki/Martin_Shkreli
- Naked Short Sell https://en.wikipedia.org/wiki/Naked_short_selling
- Once Upon a Time in Shaolin https://en.wikipedia.org/wiki/Once_Upon_a_Time_in_Shaolin
- Xconomy https://xconomy.com/san-diego/2019/08/22/retrophin-sinks-as-drug-pharma-bro-martin-shkreli-co-invented-fails/
- Music: The 6 is Silent by Skyjelly
Start for FREE
Disclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.
The podcast Controversial Figures is embedded on this page from an open RSS feed. All files, descriptions, artwork and other metadata from the RSS-feed is the property of the podcast owner and not affiliated with or validated by Podplay.